“…It is upregulated in lung, prostate, and breast carcinomas; its level of expression in melanoma correlates with metastatic capacity; and its deletion reduces metastases and prolongs survival in a mouse model of melanoma ( Bidkhori et al., 2013 ; Cao et al., 2014 ; Arjonen et al., 2014 ; Sun et al., 2015 ; Makowska et al., 2015 ; Tokuo et al., 2018 ). In addition, MYO10 plays a role in mitosis by localizing a variety of mitotic and spindle regulators, including microtubules, TPX2, and Wee1, through the MyTH4/FERM domain in its C-terminal tail ( Kwon et al., 2015 ; Woolner et al., 2008 ; Sandquist et al., 2018 ). MYO10 also binds several signaling proteins, including β integrins and PKCι ( Zhang et al., 2004 ; Linch et al., 2013 ).…”